IPO Information & documents

Get startedSubscribe

Investor centre

Prospectus

30th September 2021 | PDF

Offer Price Announcement

30th September 2021 | PDF

Additional resources

Admission of Over-allotment Option Shares

8th October 2021 | PDF

Announcement of Admission to trading

5th October 2021 | PDF

Exercise of Over-allotment Option

5th October 2021 | PDF

Prospectus summary

30th September 2021 | PDF

Announcement of Approval and Publication of Prospectus

30th September 2021 | PDF

Accountants report on Historical Financial Information

30th September 2021 | PDF

Articles of Association of Oxford Nanopore Technologies plc (on Admission)

30th September 2021 | PDF

Deloitte consent letter (Prospectus)

30th September 2021 | PDF

DeciBio Prospectus Consent Letter

30th September 2021 | PDF

Health Advances Consent Letter (Prospectus)

30th September 2021 | PDF

Pricing Statement

30th September 2021 | PDF

Confirmation of Intention to Float

16th September 2021 | PDF

Financial Conduct Authority Approves Registration Document

13th September 2021 | PDF

Registration Document

9th September 2021 | PDF

Expected Intention To Float

9th September 2021 | PDF

Articles of Association for Oxford Nanopore Technologies Limited

9th September 2021 | PDF

Oxford Nanopore Technologies Limited Historical Financial Information

9th September 2021 | PDF

Accountants report on the Historical Financial Information

9th September 2021 | PDF

DeciBio Report

9th September 2021 | PDF

Health Advances Report

9th September 2021 | PDF

Deloitte LLP consent letter

9th September 2021 | PDF

DeciBio consent letter

9th September 2021 | PDF

Health Advances consent letter

9th September 2021 | PDF